TRANS Government Research Act

Nancy Mace

Republican · SC · Representative

Source: Congress.gov · FEC

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Referred to the House Committee on Energy and Commerce.

2026-08-20

Source: Congress.gov

Plain-English summary pending. Introduced on 2026-08-20. Check back soon — summaries are generated as bills progress through Congress.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 10127 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 10127 To prohibit the use of Federal funds to conduct, support, or fund research that studies the effects of gender-related medical treatment, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES August 20, 2026 Ms. Mace introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To prohibit the use of Federal funds to conduct, support, or fund research that studies the effects of gender-related medical treatment, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Terminating Radical Attempts to Negate Sex Through Government Research Act'' or the ``TRANS Government Research Act''. SEC. 2. PROHIBITION ON AVAILABILITY OF FEDERAL FUNDS FOR CERTAIN RESEARCH. (a) In General.--Notwithstanding any other provision of law, no Federal funds may be made available to directly or indirectly conduct, support, or fund covered research. (b) Definitions.--In this section: (1) Covered research.--The term ``covered research'' means research that studies the effects of-- (A) gender-related medical treatment; or (B) any other means of altering the body or physical appearance of a person to no longer correspond to the sex of such person, including by-- (i) disrupting the natural development of the body of such person; (ii) inhibiting the natural functions of the body of such person; and (iii) modifying the physical appearance or attire of such person. (2) Female.--The term ``female'' means an individual who, but for a developmental or genetic anomaly or historical accident, naturally has, had, will have, or would have a reproductive system that produces, transports, and utilizes eggs for fertilization. (3) Gender-related medical treatment.--The term ``gender- related medical treatment'' means-- (A) with respect to an individual who is female, medical treatment provided for the purpose of addressing the perception of such individual that such individual is not female, including-- (i) a surgical procedure, including-- (I) a vaginectomy; (II) a hysterectomy; (III) an oophorectomy; (IV) the reconstruction of the urethra; (V) a metoidioplasty; (VI) a phalloplasty; (VII) a salpingo-oophorectomy; (VIII) a scrotoplasty; (IX) the implantation of erection or testicular protheses; (X) a subcutaneous mastectomy; (XI) vocal cord surgery; (XII) pectoral implantation; and (XIII) penile transplantation; (ii) an exogenous dose of testosterone or other androgen; and (iii) a puberty blocker, including-- (I) a gonadotropin-releasing hormone (GnRH) agonist; and (II) a synthetic drug that-- (aa) suppresses the production of estrogen and progesterone; or (bb) delays or suppresses pubertal development; and (B) with respect to an individual who is male, medical treatment provided for the purpose of addressing the perception of such individual that such individual is not male, including-- (i) a surgical procedure, including-- (I) a penectomy; (II) an orchiectomy; (III) a vaginoplasty; (IV) a clitoroplasty; (V) a vulvoplasty; (VI) an augmentation mammoplasty; (VII) facial feminization surgery; (VIII) vocal cord surgery; (IX) a chondrolaryngoplasty; (X) gluteal augmentation; and (XI) uterine transplantation; (ii) an exogenous dose of estrogen; and (iii) a puberty blocker, including-- (I) a gonadotropin-releasing hormone (GnRH) agonist; and (II) a synthetic drug that-- (aa) suppresses the production of testosterone; or (bb) delays or suppresses pubertal development. (4) Male.--The term ``male'' means an individual who, but for a developmental or genetic anomaly or historical accident, naturally has, had, will have, or would have a reproductive system that produces, transports, and utilizes sperm for fertilization. (5) Sex.--The term ``sex'' means the biological determination with respect to whether an individual is male…

or female. <all>

• HR10145SOUND Pesticide Research Act
  Referred to Committee · 2026-08-24
• HR10144Pesticide Harm Accountability Act
  Referred to Committee · 2026-08-24
• HR10098Restoring the Death Penalty in DC Act
  Referred to Committee · 2026-08-13
• HR5235Skills-Based Federal Contracting Act of 2025
  Passed House · 2026-08-06